Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Iridex ( (IRIX) ) has issued an announcement.
On May 14, 2025, Iridex Corporation received a notification of non-compliance from Nasdaq due to not meeting the continued listing standards based on its quarterly report for the period ending March 29, 2025. However, by August 27, 2025, the company had regained compliance with the Nasdaq listing standards by meeting the minimum stockholders’ equity requirement of $2,500,000, as confirmed by Nasdaq’s formal notification. This resolution ensures Iridex’s continued listing on the Nasdaq Capital Market, closing the matter and stabilizing its market position.
The most recent analyst rating on (IRIX) stock is a Hold with a $1.50 price target. To see the full list of analyst forecasts on Iridex stock, see the IRIX Stock Forecast page.
Spark’s Take on IRIX Stock
According to Spark, TipRanks’ AI Analyst, IRIX is a Neutral.
Iridex’s overall stock score is primarily impacted by its weak financial performance, characterized by declining revenues and negative profit margins. While the earnings call and corporate events provide some positive outlooks, the technical analysis and valuation concerns weigh heavily on the score.
To see Spark’s full report on IRIX stock, click here.
More about Iridex
Iridex Corporation is a global leader in the development, manufacturing, and marketing of innovative laser-based medical systems, delivery devices, and consumable instrumentation for the ophthalmology market. The company’s proprietary MicroPulse® technology offers a differentiated laser treatment for sight-threatening eye conditions, including glaucoma and diabetic macular edema. Iridex products are distributed in the United States through a direct sales force and internationally through independent distributors in over 100 countries.
Average Trading Volume: 121,845
Technical Sentiment Signal: Sell
Current Market Cap: $23.79M
For an in-depth examination of IRIX stock, go to TipRanks’ Overview page.